ANK3 gene expression in bipolar disorder and schizophrenia

British Journal of Psychiatry

Volumn 205, Issue 3, 2014, Pages 244-245

  Wirgenes, Katrine Verena ^a,b   Tesli, Martin ^a,b   Inderhaug, Elin ^a,b   Athanasiu, Lavinia ^a,b   Agartz, Ingrid ^a,b   Melle, Ingrid ^a,b   Hughes, Timothy ^c   Andreassen, Ole Andreas ^a,b   Djurovic, Srdjan ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANKYRIN 3; CIS ACTING ELEMENT; MESSENGER RNA; UNCLASSIFIED DRUG; ANK3 PROTEIN, HUMAN;

ARTICLE; BIPOLAR DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY KIT; QUANTITATIVE TRAIT LOCUS; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TRANSCRIPTION INITIATION SITE; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANKYRINS; BIPOLAR DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84906971571     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.145433     Document Type: Article

References (9)

1. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-83.
2. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-76.
3. Roussos P, Katsel P, Davis KL, Bitsios P, Giakoumaki SG, Jogia J, et al. Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry 2012; 69: 7-15.
4. Roussos P, Giakoumaki SG, Georgakopoulos A, Robakis NK, Bitsios P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord 2011; 13: 250-9.
5. Linke J, Witt SH, King AV, Nieratschker V, Poupon C, Gass A, et al. Genome-wide supported risk variant for bipolar disorder alters anatomical connectivity in the human brain. Neuroimage 2012; 59: 3288-96.
6. Rueckert EH, Barker D, Ruderfer D, Bergen SE, O'Dushlaine C, Luce CJ, et al. Cis-acting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder. Mol Psychiatry 2013; 18: 922-9.
7. Kato T, Hayashi-Takagi A, Toyota T, Yoshikawa T, Iwamoto K. Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet 2011; 56: 779-83.
8. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624-9.
9. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 261-8.